Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Other Non Operating Income came in at -$57000.0 in Q1 2026, up 56.15% year-on-year from -$36502.5 in Q1 2025, and down 11.76% quarter-over-quarter from -$51000.0 in Q4 2025.
Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$57000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 56.15% year-over-year to -$57000.0 in Q1 2026; TTM through Mar 2026 was -$92000.0, a 68.06% increase from a year earlier, with the FY2025 full-year figure at -$165000.0, down 1.23% from the prior year.
- Other Non Operating Income retreated to -$57000.0 in Q1 2026 per CTNM's latest filing, from -$51000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $183000.0 in Q3 2025 and bottomed at -$167000.0 in Q2 2025.
- The 4-year median for Other Non Operating Income is -$47000.0 (2023), against an average of -$43307.7.
- Biggest YoY gain for Other Non Operating Income was 638.24% in 2025; the steepest drop was 2066.67% in 2025.
- Year by year, Other Non Operating Income stood at -$47000.0 in 2023, then changed by 0.0% to -$47000.0 in 2024, then dropped by 8.51% to -$51000.0 in 2025, then declined by 11.76% to -$57000.0 in 2026.
- Per Business Quant, the three latest CTNM Other Non Operating Income figures stand at -$57000.0 (Q1 2026), -$51000.0 (Q4 2025), and $183000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Sep 30, 2025 | 183,000.00 |
| Jun 30, 2025 | -167,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | -47,000.00 |
| Sep 30, 2023 | -36,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | -18,000.00 |